Alzheimer’s drug Leqembi receives full FDA approval
The approval clears the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
- Maine's Changing Climate
- Maine Things To Do
- Lewiston Strong
- Let's Talk About It
- Myler Makes It
- PFAS
- Ticks and Lyme
- Dempsey Challenge
- Gardening with Gutner
- Feed Maine
- Coats and Toys for Kids
- Advertise With Us
- Voice of the Voter
- Closings and Delays
- Gift Shop
- NCM Jobs
- Meet The Team
- VERIFY
- Closing Registration
- Project Heat
- Varsity Club